Get 20M+ Full-Text Papers For Less Than $1.50/day. Subscribe now for You or Your Team.

Learn More →

Fludarabine, cyclophosphamide, and rituximab treatment achieves long-term disease-free survival in IGHV-mutated chronic lymphocytic leukemia

Fludarabine, cyclophosphamide, and rituximab treatment achieves long-term disease-free survival... http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Blood Unpaywall

Fludarabine, cyclophosphamide, and rituximab treatment achieves long-term disease-free survival in IGHV-mutated chronic lymphocytic leukemia

Loading next page...
 
/lp/unpaywall/fludarabine-cyclophosphamide-and-rituximab-treatment-achieves-long-MGQQ5pFnw7

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
Unpaywall
ISSN
0006-4971
DOI
10.1182/blood-2015-09-667675
Publisher site
See Article on Publisher Site

Abstract

Journal

BloodUnpaywall

Published: Jan 21, 2016

There are no references for this article.